Home

túloz ököl kavics notizie su gilead sciences szegény toxicitás Kényelmetlenség

Gilead Sciences wins reversal of $1.2 bln award in patent case with Bristol  Myers | Reuters
Gilead Sciences wins reversal of $1.2 bln award in patent case with Bristol Myers | Reuters

Gilead Sciences Aims to Add Labs at Foster City Campus
Gilead Sciences Aims to Add Labs at Foster City Campus

New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio -  WSJ
New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio - WSJ

Gilead guts its filgotinib plans, dealing a blow to O'Day's diversification  dream | Fierce Pharma
Gilead guts its filgotinib plans, dealing a blow to O'Day's diversification dream | Fierce Pharma

What's Happening With Gilead Sciences Stock?
What's Happening With Gilead Sciences Stock?

Gilead (GILD) Boosts Sales Forecast on Demand for Covid-19 Drug - Bloomberg
Gilead (GILD) Boosts Sales Forecast on Demand for Covid-19 Drug - Bloomberg

Alabama Doe, et al., v. Gilead Sciences, Inc. - AIDS Law Project
Alabama Doe, et al., v. Gilead Sciences, Inc. - AIDS Law Project

Gilead Sciences News, Gilead Sciences Quote, GILD Quote - StreetInsider.com
Gilead Sciences News, Gilead Sciences Quote, GILD Quote - StreetInsider.com

How Is Gilead (NASDAQ:GILD) Stock Positioned Ahead of ESMO This Week?
How Is Gilead (NASDAQ:GILD) Stock Positioned Ahead of ESMO This Week?

Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report |  AlphaStreet
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report | AlphaStreet

Gilead Sciences Ranked No. 6 overall, and No. 2 in Health Care & Life  Sciences Industry, in Newsweek's List of Most Responsible American Companies
Gilead Sciences Ranked No. 6 overall, and No. 2 in Health Care & Life Sciences Industry, in Newsweek's List of Most Responsible American Companies

FDA swats away Gilead's hepatitis D treatment bulevirtide
FDA swats away Gilead's hepatitis D treatment bulevirtide

Gilead Sciences considered Durham before picking Raleigh for 275-job  expansion - Triangle Business Journal
Gilead Sciences considered Durham before picking Raleigh for 275-job expansion - Triangle Business Journal

Drugmaker Gilead Alleges Counterfeiting Ring Sold Its HIV Drugs - WSJ
Drugmaker Gilead Alleges Counterfeiting Ring Sold Its HIV Drugs - WSJ

Gilead Sciences raises full-year 2022 outlook following Q3 beats  (NASDAQ:GILD) | Seeking Alpha
Gilead Sciences raises full-year 2022 outlook following Q3 beats (NASDAQ:GILD) | Seeking Alpha

Gilead Breast-Cancer Drug Delays Progression by 1.5 Months - Bloomberg
Gilead Breast-Cancer Drug Delays Progression by 1.5 Months - Bloomberg

Why Is Gilead Sciences (GILD) Stock Up Today? | InvestorPlace
Why Is Gilead Sciences (GILD) Stock Up Today? | InvestorPlace

Gilead Sciences will lay off 114 staffers based out of former Immunomedics  headquarters | Fierce Pharma
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters | Fierce Pharma

Gilead Sciences Catches Upgrade On Kite Pharma Acquisition, CAR-T  Opportunity | Stock News & Stock Market Analysis - IBD
Gilead Sciences Catches Upgrade On Kite Pharma Acquisition, CAR-T Opportunity | Stock News & Stock Market Analysis - IBD